• |

Natan Bar-Chama, M.D.

Dr. Natan Bar-Chama

Dr. Natan Bar-Chama is the Director of the Center of Male Reproductive Health at RMA of New York. He is also the Director of Male Reproductive Medicine and Surgery at Mount Sinai Hospital and is an associated professor of urology at the Mount Sinai School of Medicine. His subspecialty clinical practice is exclusively dedicated to male reproductive medicine and microsurgical reconstruction for the treatment of male-factor infertility (vasovasostomy, varicocelectomy, testicular and epididymal sperm retrieval, and vasectomy). Dr. Bar-Chama is a board certified urologist who received his medical degree with special distinction for research in male infertility and completed his urology residency at the Albert Einstein College of Medicine. Dr. Bar-Chama was awarded the prestigious New York Academy of Medicine F.C. Valentine Fellowship and received subspecialty training in male reproductive medicine and surgery at the Baylor College of Medicine in Houston, Texas.

In 1998, Dr. Bar-Chama received the Pfizer Scholars in Urology Award for leadership, innovation, and outstanding achievement in urological science. He was recently awarded the 2008 Humanitarian Award by Bonei Olam. Dr. Bar-Chama serves on the Board of Directors of the American Fertility Association and was awarded the American Fertility Association Family Building Award in 2000. He currently serves on the Board of Directors of the Society for Male Reproduction and Urology (SMRU) of the American Society of Reproductive Medicine (ASRM) as well as on the Board of Directors of the Society for the Study of Male Reproduction (SSMR). Since 2005, Dr. Bar-Chama has been listed every year in New York Magazine’s “Best Doctors” issue as a top urologist, including the recently released 2009 list.

The RMA Network

What's new?

Receive the latest updates from RMA!

RMANJ Research: Improving IVF

Original Research from RMANJ has Broad-Reaching Implications for Improving Success in IVF

Research Designated “Seminal Contribution” in April Issue of Fertility & Sterility

A new study conducted by Reproductive Medicine Associates of New Jersey has shown that an optimized method of Comprehensive Chromosome Screening (CCS) is the first technology capable of accurate aneuploidy screening (abnormal number of chromosomes) of all 24 chromosomes in four hours.

Learn more
Welcome to RMA of New York

This video introduces you to the world-renowned, full service fertility center, its Reproductive Endocrinologists, Urologist, Complementary Care team and highly qualified staff.

See Video